The different sequences of CDK4/6 inhibitor and mTOR inhibitor in HR+/HER2-advanced breast cancer: A multicenter real-world study.
Liao Y, Tan Y, Li Y, Ma F, Wang J, Zhang P, Li Q, Li Q, Luo Y, Lan B, Chen S, Xu B, Jiang H, Zhao W, Fan Y.
Liao Y, et al. Among authors: li y, li q.
Heliyon. 2024 Sep 19;10(19):e38147. doi: 10.1016/j.heliyon.2024.e38147. eCollection 2024 Oct 15.
Heliyon. 2024.
PMID: 39386840
Free PMC article.